DE69317877T2 - 4''-deoxyerythromycinderivate - Google Patents

4''-deoxyerythromycinderivate

Info

Publication number
DE69317877T2
DE69317877T2 DE69317877T DE69317877T DE69317877T2 DE 69317877 T2 DE69317877 T2 DE 69317877T2 DE 69317877 T DE69317877 T DE 69317877T DE 69317877 T DE69317877 T DE 69317877T DE 69317877 T2 DE69317877 T2 DE 69317877T2
Authority
DE
Germany
Prior art keywords
derivatives
deoxyerythromycine
erythromycin
enhancers
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69317877T
Other languages
English (en)
Other versions
DE69317877D1 (en
Inventor
Paul A Lartey
Hugh N Nellans
Larry L Klein
Ramin Faghih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69317877D1 publication Critical patent/DE69317877D1/de
Application granted granted Critical
Publication of DE69317877T2 publication Critical patent/DE69317877T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69317877T 1992-01-21 1993-01-19 4''-deoxyerythromycinderivate Expired - Fee Related DE69317877T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82349092A 1992-01-21 1992-01-21
US94415092A 1992-09-11 1992-09-11
PCT/US1993/000468 WO1993013780A1 (en) 1992-01-21 1993-01-19 4''-deoxyerythromycin derivatives

Publications (2)

Publication Number Publication Date
DE69317877D1 DE69317877D1 (en) 1998-05-14
DE69317877T2 true DE69317877T2 (de) 1998-10-29

Family

ID=27124738

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69317877T Expired - Fee Related DE69317877T2 (de) 1992-01-21 1993-01-19 4''-deoxyerythromycinderivate

Country Status (16)

Country Link
US (3) US5578579A (de)
EP (1) EP0623021B1 (de)
JP (1) JP2662094B2 (de)
KR (1) KR0179379B1 (de)
AT (1) ATE164848T1 (de)
AU (1) AU656462B2 (de)
CA (1) CA2125478A1 (de)
DE (1) DE69317877T2 (de)
DK (1) DK0623021T3 (de)
ES (1) ES2115760T3 (de)
HK (1) HK1010054A1 (de)
HU (1) HU211337A9 (de)
IL (1) IL104437A (de)
MX (1) MX9300278A (de)
PH (1) PH31561A (de)
WO (1) WO1993013780A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
US5922849A (en) * 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
US5760198A (en) * 1997-01-17 1998-06-02 Abbott Laboratories Process for preparation of 4"-deoxyerythromycins A and B
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US5883236A (en) * 1997-11-19 1999-03-16 Abbott Laboratories Process for N-desmethylating erythromycins and derivatives thereof
US5932710A (en) * 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US6040440A (en) * 1998-03-06 2000-03-21 Abbott Laboratories Hypophosphite deoxygenation reactions in the synthesis of erythromycin derivatives
US6084079A (en) * 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
EP1255763A2 (de) 2000-02-18 2002-11-13 Kosan Biosciences, Inc. Motilid-verbindungen
WO2002064092A2 (en) 2001-02-15 2002-08-22 Kosan Biosciences, Inc. Method for evaluating therapeutic efficacy
AU2003273254B2 (en) * 2002-08-29 2008-10-30 Bristol-Myers Squibb Company Motilide compounds
US7635714B2 (en) 2002-10-25 2009-12-22 Chugai Seiyaku Kabushiki Kaisha Methods of treating dyschezia
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
EP1960414A4 (de) * 2005-12-08 2008-12-17 Pfizer VERFAHREN ZUR DEMETHYLIERUNG DER 3ý-DIMETHYLAMINOGRUPPE VON ERYTHROMYCINVERBINDUNGEN
CA2662897C (en) 2006-09-11 2017-11-07 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
ES2401467T3 (es) 2006-12-05 2013-04-19 Bristol-Myers Squibb Company Polimorfos de motilida
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849396A (ja) * 1981-09-07 1983-03-23 Toyo Jozo Co Ltd ４″−デオキシ−１４員環マクロライド抗生物質
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
DE3689758T2 (de) * 1985-08-31 1994-08-18 Kitasato Inst Erythromycinderivat und Verfahren zu dessen Herstellung.
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
MY103197A (en) * 1987-02-20 1993-05-29 Kitasato Inst A growth promoting composition and production thereof
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
HU211337A9 (en) 1995-11-28
MX9300278A (es) 1993-12-31
US5654411A (en) 1997-08-05
IL104437A (en) 1997-03-18
PH31561A (en) 1998-11-03
DE69317877D1 (en) 1998-05-14
IL104437A0 (en) 1993-05-13
JP2662094B2 (ja) 1997-10-08
WO1993013780A1 (en) 1993-07-22
EP0623021A1 (de) 1994-11-09
KR0179379B1 (ko) 1999-04-01
EP0623021B1 (de) 1998-04-08
HK1010054A1 (en) 1999-06-11
AU656462B2 (en) 1995-02-02
CA2125478A1 (en) 1993-07-22
US5578579A (en) 1996-11-26
ATE164848T1 (de) 1998-04-15
US5834438A (en) 1998-11-10
EP0623021A4 (en) 1994-12-14
JPH06511257A (ja) 1994-12-15
ES2115760T3 (es) 1998-07-01
AU3586193A (en) 1993-08-03
DK0623021T3 (da) 1999-02-08

Similar Documents

Publication Publication Date Title
ATE164848T1 (de) 4''-deoxyerythromycinderivate
DE69705300T2 (de) Cyclopropylalkansäurederivate
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
DE69705829T2 (de) Meta-substituierte phenylsulphonamidderivate
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DE69330601D1 (de) Serotoninergische ergolin derivate
AP9801235A0 (en) Erythromycin derivatives.
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
ES2133567T3 (es) Derivados de eritromicina.
ATE42305T1 (de) Antibiotika, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IT1261994B (it) Derivati guanidinici ad uso terapeutico.
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee